• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管球瘤进展过程中的p53和p16INK4A突变

p53 and p16INK4A mutations during the progression of glomus tumor.

作者信息

Güran S, Tali E T

机构信息

Gülhane Medical Faculty, Department of Medical Biology and Genetics, Ankara, Turkey.

出版信息

Pathol Oncol Res. 1999;5(1):41-5. doi: 10.1053/paor.1999.0041.

DOI:10.1053/paor.1999.0041
PMID:10079377
Abstract

Glomus tumors are significantly rare tumors of carotid body. The great majority of these tumors are benign in character. Here we present two brothers with hereditary glomus jugulare tumor who had consanguineous parents. Radiotherapy was applied approximately 8 and 10 years ago for treatment in both cases. Eight years later, one of these cases came to our notice due to relapse. The mutation pattern of p53, p57KIP2, p16INK4A and p15NK4B genes which have roles in the cell cycle, was analyzed in tumor samples obtained from the two affected cases in the initial phase and from one of these cases at relapse. The DNA sample obtained from the case in initial diagnosis phase revealed no p53, p57KIP2, p16INK4A or p15INK4B mutation. He is still in remission phase. Despite the lack of p53, p57KIP2, p16INK4A and p15INK4B mutation at initial diagnosis the tumor DNA of the other case in relapse revealed p53 codon 243 (ATG-->ATC; met-->ile) and p16 codon 97 (GAC-->AAC; asp-->asn) missense point mutations. No loss of heterozygosity in p53 and p16INK4A was observed by microsatellite analysis of tumoral tissues in these cases. P53 and p16INK4A mutations observed in relapse phase were in conserved regions of both genes. No previous reports have been published with these mutations in glomus tumor during progression. The mutation observed in this case may due to radiotherapy. In spite of this possibility, the missense point mutations in conserved region of p53 and p16INK4A genes may indicate the role of p53 and p16INK4A in tumor progression of glomus tumors.

摘要

球旁细胞瘤是非常罕见的颈动脉体肿瘤。这些肿瘤绝大多数为良性。在此,我们报告两兄弟患有遗传性颈静脉球瘤,其父母为近亲。大约在8年和10年前,这两例患者均接受了放射治疗。8年后,其中1例因复发引起我们的注意。分析了在疾病初期从这两例患病患者以及复发时从其中1例患者获取的肿瘤样本中,在细胞周期中起作用的p53、p57KIP2、p16INK4A和p15NK4B基因的突变模式。在初始诊断阶段获取的病例的DNA样本未显示p53、p57KIP2、p16INK4A或p15INK4B突变。他仍处于缓解期。尽管在初始诊断时缺乏p53、p57KIP2、p16INK4A和p15INK4B突变,但另一例复发患者的肿瘤DNA显示p53密码子243(ATG→ATC;甲硫氨酸→异亮氨酸)和p16密码子97(GAC→AAC;天冬氨酸→天冬酰胺)错义点突变。通过对这些病例肿瘤组织的微卫星分析,未观察到p53和p16INK4A杂合性缺失。在复发阶段观察到的p53和p16INK4A突变位于这两个基因的保守区域。此前尚无关于球旁细胞瘤进展过程中这些突变的报道。该病例中观察到的突变可能归因于放射治疗。尽管有这种可能性,但p53和p16INK4A基因保守区域的错义点突变可能表明p53和p16INK4A在球旁细胞瘤的肿瘤进展中起作用。

相似文献

1
p53 and p16INK4A mutations during the progression of glomus tumor.血管球瘤进展过程中的p53和p16INK4A突变
Pathol Oncol Res. 1999;5(1):41-5. doi: 10.1053/paor.1999.0041.
2
P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia.慢性粒细胞白血病进展过程中的P53、p15INK4B、p16INK4A和p57KIP2突变
Haematologia (Budap). 1998;29(3):181-93.
3
Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li-Fraumeni syndrome family.李-弗劳梅尼综合征家族中的遗传性TP53基因第292密码子突变和体细胞P16INK4A基因第94密码子突变
Cancer Genet Cytogenet. 1999 Sep;113(2):145-51. doi: 10.1016/s0165-4608(98)00276-3.
4
Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.人甲状腺癌细胞系和原发性甲状腺癌中细胞周期蛋白依赖性激酶抑制剂p15INK4b和p16INK4a的遗传和表观遗传改变。
Cancer. 1998 Nov 15;83(10):2185-93.
5
Expression of cell cycle regulatory genes in chronic myelogenous leukemia.慢性粒细胞白血病中细胞周期调控基因的表达
Haematologica. 1998 Sep;83(9):771-7.
6
Infrequent mutations of p16INK4A and p15INK4B genes in human pituitary adenomas.人类垂体腺瘤中p16INK4A和p15INK4B基因的罕见突变
Eur J Endocrinol. 1997 Jan;136(1):74-80. doi: 10.1530/eje.0.1360074.
7
Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.印度乳腺癌中p53、fhit、p16INK4a/p19ARF和H-ras基因的突变谱
Int J Oncol. 2000 Nov;17(5):1031-5. doi: 10.3892/ijo.17.5.1031.
8
Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China.在中国林县,人食管癌中p16INK4a基因的异常甲基化和p15INK4b基因的缺失是常见事件。
Carcinogenesis. 1999 Jan;20(1):77-84. doi: 10.1093/carcin/20.1.77.
9
Cumulation of TP53 mutations and p16INK4A/p15INK4B homozygous deletions in human papilloma virus type 16 positive scrotal cancer.16型人乳头瘤病毒阳性阴囊癌中TP53突变及p16INK4A/p15INK4B纯合缺失的累积情况
Cancer Genet Cytogenet. 1999 Mar;109(2):108-13. doi: 10.1016/s0165-4608(98)00155-1.
10
Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies.原发性淋巴恶性肿瘤中参与细胞周期负调控的多个肿瘤抑制基因失活,包括MTS1/p16INK4A/CDKN2、MTS2/p15INK4B、p53和Rb基因。
Blood. 1996 Jun 15;87(12):4949-58.

引用本文的文献

1
Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.肾上腺及肾上腺外嗜铬细胞瘤和副神经节瘤的分子遗传学改变
Endocr Pathol. 2003 Winter;14(4):329-50. doi: 10.1385/ep:14:4:329.

本文引用的文献

1
Cumulation of TP53 mutations and p16INK4A/p15INK4B homozygous deletions in human papilloma virus type 16 positive scrotal cancer.16型人乳头瘤病毒阳性阴囊癌中TP53突变及p16INK4A/p15INK4B纯合缺失的累积情况
Cancer Genet Cytogenet. 1999 Mar;109(2):108-13. doi: 10.1016/s0165-4608(98)00155-1.
2
A novel germ-line mutation in the noncoding region of the p53 gene in a Li-Fraumeni family.一个李-佛美尼家族中p53基因非编码区的新型种系突变。
Cancer Genet Cytogenet. 1998 May;103(1):1-6. doi: 10.1016/s0165-4608(97)00258-6.
3
ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.
ARF促进MDM2降解并使p53稳定:ARF-INK4a基因座缺失会损害Rb和p53肿瘤抑制途径。
Cell. 1998 Mar 20;92(6):725-34. doi: 10.1016/s0092-8674(00)81401-4.
4
The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.Ink4a肿瘤抑制基因产物p19Arf与MDM2相互作用,并中和MDM2对p53的抑制作用。
Cell. 1998 Mar 20;92(6):713-23. doi: 10.1016/s0092-8674(00)81400-2.
5
Low frequency of p57KIP2 mutation in Beckwith-Wiedemann syndrome.贝克威思-维德曼综合征中p57KIP2突变的低频率
Am J Hum Genet. 1997 Aug;61(2):304-9. doi: 10.1086/514858.
6
Frequent allelic losses of 9p21 markers and low incidence of mutations at p16(CDKN2) gene in non-Hodgkin lymphomas of B-cell lineage.
Cancer Genet Cytogenet. 1997 Oct 1;98(1):63-8. doi: 10.1016/s0165-4608(96)00400-1.
7
A high-resolution STS, EST, and gene-based physical map of the hereditary paraganglioma region on chromosome 11q23.11号染色体q23区域遗传性副神经节瘤的高分辨率STS、EST和基于基因的物理图谱。
Genomics. 1997 Sep 1;44(2):214-21. doi: 10.1006/geno.1997.4880.
8
Malignant glomus tumor: a case report and review of the literature.恶性血管球瘤:一例病例报告及文献综述
Am J Surg Pathol. 1997 Sep;21(9):1096-103. doi: 10.1097/00000478-199709000-00015.
9
First experiences with genetic counselling based on predictive DNA diagnosis in hereditary glomus tumours (paragangliomas).遗传性球瘤(副神经节瘤)基于预测性DNA诊断的遗传咨询首次经验。
J Med Genet. 1996 May;33(5):379-83. doi: 10.1136/jmg.33.5.379.
10
CDKN2A (p16INK4A) somatic and germline mutations.CDKN2A(p16INK4A)体细胞和种系突变。
Hum Mutat. 1996;7(4):294-303. doi: 10.1002/(SICI)1098-1004(1996)7:4<294::AID-HUMU2>3.0.CO;2-9.